Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway - Wikidata - wikimedia - TriplyDB

Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway

Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway

http://www.wikidata.org/entity/Q34939962

about

Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation Pathogenesis of kidney disease in systemic lupus erythematosus.Lupus pathobiology based on genomics.Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.T-cell and B-cell signaling biomarkers and treatment targets in lupus.Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus Clinical associations of serum interleukin-17 in systemic lupus erythematosus.Requirements for innate immune pathways in environmentally induced autoimmunity.B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.T cell and dendritic cell abnormalities synergize to expand pro-inflammatory T cell subsets leading to fatal autoimmunity in B6.NZBc1 lupus-prone mice The role of cytokine in the lupus nephritis.The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.Cytokine disturbances in systemic lupus erythematosus.The discovery and development of belimumab: the anti-BLyS-lupus connection Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5.Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus.Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.Suppressive oligodeoxynucleotides promote the development of Th17 cells.Immune and inflammatory role in renal disease.Th1 and Th17 cells induce proliferative glomerulonephritis.Interleukin-17 and systemic lupus erythematosus: current concepts.The role of dendritic cells in the pathogenesis of systemic lupus erythematosus.The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus.Future prospects in biologic therapy for systemic lupus erythematosus.Safety of off-label biologicals in systemic lupus erythematosus.MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.Interluekin-17A (IL17A).IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.Haploinsufficiency of NADPH Oxidase Subunit Neutrophil Cytosolic Factor 2 Is Sufficient to Accelerate Full-Blown Lupus in NZM 2328 Mice.The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.Phage display-derived human antibodies in clinical development and therapy Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy.

P2860

Q24300244-4BF1BCAC-CB46-4D27-AF91-F77AC54712EF Q28477172-1D2141A9-3085-466E-9609-E8C8444919D4 Q30434907-67528F6D-6B06-4350-9016-EF3DA7C42924 Q33364409-4EFF722D-9AF6-4879-A59D-882DA498FE8F Q33601679-34E68B50-D3B2-4843-AAD3-D18E47441A75 Q33608479-A503B1EB-3219-4B55-871C-0BF60985B4A3 Q33718893-99E79C28-8692-4562-9586-43C0E1343014 Q33923351-317585BA-9EF3-4F79-B9FD-53C5FFE43177 Q34365880-EE3B1162-F230-4B05-B327-56804028A3C2 Q34655526-22E367CE-6EE7-4F08-94BA-6425C8336E1B Q34781487-D39F5450-8F29-4D19-A160-06A4DBCCF822 Q35000797-EE887F98-36F1-4C82-8629-7955461DB39C Q35418333-653428E9-546F-4D34-A5BF-C07C8A7D14B6 Q35579076-FCB7917B-AD9D-4A29-B9C7-8C934E28E58F Q35617573-F95C25FE-9490-4E49-8D41-43D86489072E Q35691272-E6E68FE2-32C3-41F9-90C4-FA0067CE844F Q35798968-9EDAC1B7-53F6-4F93-BA72-A4008135B1F3 Q35849486-3F0D8FB1-9654-4856-A06A-B5FFD2170334 Q35916695-2A1E12AB-2C07-4B4B-9A1E-07FC772456E3 Q36718109-674BFB2F-0D7B-440F-970F-5F800DDB5311 Q36745567-CB39F7F6-0498-4E74-9835-18DB47ED71E5 Q36976397-76390634-D4C6-4D2E-A11B-EF4D98987126 Q37243199-584105EF-BC7B-4036-B856-014CE6E232B4 Q37477762-A0703FD1-4C8D-41F0-9CAE-9A7E1E664AF5 Q37552021-309272CF-2105-4FB6-9007-40CB8C86D2DF Q37737799-98CF4BEA-6AD8-4BEB-925E-899AD8CDF8BA Q37852758-918CB236-F9ED-4B0D-A1FA-1461F60C4EA6 Q37864851-8EC213CD-048D-4BFD-91F5-601FE66649F5 Q38135706-7EFF4581-0DA0-45C6-A249-71577717AFE1 Q38284560-163D05A8-6D8C-42B0-99D0-08B6288E5A68 Q38655827-D1AE0CEB-581B-4B53-A2BF-A4F8BE9BB2F5 Q39101016-491A4357-13F9-4612-8403-4C1DC520D8DC Q39103136-D8FF84DB-2E0E-48AD-8B1F-D5E5EDFD2A02 Q39182623-2AA076CE-BC28-42DB-8503-0E94BFE54106 Q40226730-220AC6C0-AD59-468C-95BE-B5737F9DAB5F Q40695129-EF886C07-6971-4936-9C4E-4111A527ACDA Q41416393-3B1CA8DF-9218-4A6A-99B7-92B85417E4F4 Q41837557-2C5D054B-5162-4440-A04F-354A8BB02743 Q41840662-7C0ACD76-D974-4439-91B7-417462CED5EE Q41921501-798F41A6-3980-45DE-9ECC-7F3ED92EF098

P2860

Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway

http://www.wikidata.org/entity/Q34939962

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Accelerated pathological and c ...... via a Th17-associated pathway

@ast

Accelerated pathological and c ...... via a Th17-associated pathway

@en

Accelerated pathological and c ...... via a Th17-associated pathway

@nl

type

label

Accelerated pathological and c ...... via a Th17-associated pathway

@ast

Accelerated pathological and c ...... via a Th17-associated pathway

@en

Accelerated pathological and c ...... via a Th17-associated pathway

@nl

prefLabel

Accelerated pathological and c ...... via a Th17-associated pathway

@ast

Accelerated pathological and c ...... via a Th17-associated pathway

@en

Accelerated pathological and c ...... via a Th17-associated pathway

@nl

P1433

Q34939962-E86E73B0-8BC6-43E6-9A59-B3F3EB308D49

P1476

Q34939962-E1F6C967-0BFA-49E6-8D91-00EDB3B8235D

P2093

Q34939962-118F4C88-A27E-489A-B4D9-C369604D9548

Q34939962-288DDE92-933A-4303-878A-753A5EB7A815

Q34939962-2F784B7B-CE35-40D1-A916-AB6E3019390A

Q34939962-3119668F-64DE-4224-BD74-5A8C96562267

Q34939962-3A118C0B-FD9D-494A-A4F6-7834097920A5

Q34939962-49BD2BB5-9E32-456A-B36C-44AE09D02D03

Q34939962-53CCEDFC-EA41-44D8-A487-BF0CA720A397

Q34939962-59137B90-D810-4222-9210-2F44E0FEFDD6

Q34939962-781F7A84-F8DF-4BEF-BA2A-CA6E3032E1CE

Q34939962-B9DF19C0-AB1B-4B5A-A8AD-9C4FC1794315

P2860

Q34939962-043C0671-655C-49BE-8F6A-92F781595FA3

Q34939962-065F2F65-62E6-46CA-9B7F-4BA3BD572771

Q34939962-108C92F3-D394-472E-B209-4D27F578693D

Q34939962-12338E6E-1782-4874-B894-BF6C53E6DDD4

Q34939962-129D3865-B929-40D1-B31A-80A57AC512F5

Q34939962-14D93F00-AFA8-4CEE-9CE9-0FB62F32AB56

Q34939962-1777A458-1888-4E63-8FCD-A4F5F3C875DC

Q34939962-17EE8453-99A9-438D-B168-B8719E3CB7BC

Q34939962-1A9AA06B-E9B0-4996-8084-4357A27F8708

Q34939962-1C8E9907-080E-49FE-95D4-727728318AE7

P304

Q34939962-C63004E0-2A70-4048-9EA8-46112C8D6FDE

P31

Q34939962-561ECD4D-943D-468F-ACCA-92152C54BD9D

P356

Q34939962-A0D793E0-7F3B-4249-9B68-2DB5CE46A4AF

P407

Q34939962-B1D9A858-D9B6-46D7-8F56-0B0BED44653F

P433

Q34939962-0CD8911A-C218-4A3D-850A-0BF497D8004A

P478

Q34939962-568BEB40-CF40-4A67-8D15-6A8156787D53

P577

Q34939962-4699A779-2607-43F8-9CC2-1A53253847A1

P5875

Q34939962-29ADACD0-6E91-4BE5-A711-3C8C8F474176

P698

Q34939962-AA560B54-9537-43E6-A6A7-8914653C1074

P921

Q34939962-5764E4CA-6B24-40D0-8B35-E06F954892CA

Q34939962-5D40F069-C50F-45AD-93E7-75714A5B0568

P932

Q34939962-8A4BFB0C-FA2A-46DE-84CC-75CD2A9AF5C7

P356

JIMMUNOL.0802948

P1433

Journal of Immunology

P1476

Accelerated pathological and c ...... via a Th17-associated pathway

@en

P2093

Chaim O Jacob

http://www.w3.org/2001/XMLSchema#string

Chaim Putterman

http://www.w3.org/2001/XMLSchema#string

Haitao Yang

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Gao

http://www.w3.org/2001/XMLSchema#string

Juhua Wang

http://www.w3.org/2001/XMLSchema#string

Luminita Pricop

http://www.w3.org/2001/XMLSchema#string

Michael N Koss

http://www.w3.org/2001/XMLSchema#string

Noam Jacob

http://www.w3.org/2001/XMLSchema#string

Song Guo Zheng

http://www.w3.org/2001/XMLSchema#string

William Stohl

http://www.w3.org/2001/XMLSchema#string

P2860

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

A new mathematical model for relative quantification in real-time RT-PCR

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Role of cytokines in rheumatoid arthritis

NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

P304

2532-2541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0802948

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23989355

http://www.w3.org/2001/XMLSchema#string

P698

19201910

http://www.w3.org/2001/XMLSchema#string

P921

P932

2790862

http://www.w3.org/2001/XMLSchema#string